These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 1572445

  • 1. Effect of hyposensitization upon the immediate and late asthmatic reaction and upon histamine reactivity in patients allergic to house dust mite (Dermatophagoides pteronyssinus).
    Van Bever HP, Stevens WJ.
    Eur Respir J; 1992 Mar; 5(3):318-22. PubMed ID: 1572445
    [Abstract] [Full Text] [Related]

  • 2. Modification of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus) or grass pollen.
    Van Bever HP, Bosmans J, De Clerck LS, Stevens WJ.
    Allergy; 1988 Jul; 43(5):378-85. PubMed ID: 3414914
    [Abstract] [Full Text] [Related]

  • 3. Suppression of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus).
    Van Bever HP, Stevens WJ.
    Clin Exp Allergy; 1989 Jul; 19(4):399-404. PubMed ID: 2758353
    [Abstract] [Full Text] [Related]

  • 4. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
    Wang HY, Lin XP, Hao CL, Zhang CQ, Sun BQ, Zheng JP, Chen P, Sheng JY, Wu A, Zhong NS.
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N, Scheinmann P, Fadel R, Combebias A, Andre C.
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [Abstract] [Full Text] [Related]

  • 10. Evolution of the late asthmatic reaction during immunotherapy and after stopping immunotherapy.
    Van Bever HP, Stevens WJ.
    J Allergy Clin Immunol; 1990 Aug; 86(2):141-6. PubMed ID: 2384645
    [Abstract] [Full Text] [Related]

  • 11. Validated safety predictions of airway responses to house dust mite in asthma.
    Ravensberg AJ, van Rensen EL, Grootendorst DC, de Kluijver J, Diamant Z, Ricciardolo FL, Sterk PJ.
    Clin Exp Allergy; 2007 Jan; 37(1):100-7. PubMed ID: 17210047
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the long-term efficacy of 3- and 5-year house dust mite allergen immunotherapy.
    Stelmach I, Sobocińska A, Majak P, Smejda K, Jerzyńska J, Stelmach W.
    Ann Allergy Asthma Immunol; 2012 Oct; 109(4):274-8. PubMed ID: 23010234
    [Abstract] [Full Text] [Related]

  • 13. Increase in vesicular hand eczema after house dust mite inhalation provocation: a double-blind, placebo-controlled, cross-over study.
    Schuttelaar ML, Coenraads PJ, Huizinga J, De Monchy JG, Vermeulen KM.
    Contact Dermatitis; 2013 Feb; 68(2):76-85. PubMed ID: 23046099
    [Abstract] [Full Text] [Related]

  • 14. The effect of anti-allergic mattress encasings on house dust mite-induced early- and late-airway reactions in asthmatic patients. A double-blind, placebo-controlled study.
    Rijssenbeek-Nouwens LH, Oosting AJ, De Monchy JG, Bregman I, Postma DS, De Bruin-Weller MS.
    Clin Exp Allergy; 2002 Jan; 32(1):117-25. PubMed ID: 12002728
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Frequency of sensitization to D. pteronyssinus or D. farinae in children with perennial bronchial asthma].
    Zimmermann T, Mayer J.
    Monatsschr Kinderheilkd; 1985 Apr; 133(4):214-8. PubMed ID: 4000137
    [Abstract] [Full Text] [Related]

  • 18. Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial.
    Mosbech H, Deckelmann R, de Blay F, Pastorello EA, Trebas-Pietras E, Andres LP, Malcus I, Ljørring C, Canonica GW.
    J Allergy Clin Immunol; 2014 Sep; 134(3):568-575.e7. PubMed ID: 24797423
    [Abstract] [Full Text] [Related]

  • 19. The allergen specificity of the late asthmatic reaction.
    Hatzivlassiou M, Grainge C, Kehagia V, Lau L, Howarth PH.
    Allergy; 2010 Mar; 65(3):355-8. PubMed ID: 19804443
    [Abstract] [Full Text] [Related]

  • 20. Effective allergen avoidance at high altitude reduces allergen-induced bronchial hyperresponsiveness.
    Peroni DG, Boner AL, Vallone G, Antolini I, Warner JO.
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1442-6. PubMed ID: 8004296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.